At the recent 5th China International Import Expo (CIIE), Associate Professor Xu Xiaoyan's team from the Department of Business Administration of our college signed a horizontal research project agreement with Danaher Cooperation, a Fortune 500 company, entitled "Health Economics Evaluation of Diagnosis and Treatment Technologies for Benign Breast Tumors."

At the signing ceremony, Xu Xiaoyan introduced the project in detail. This project will assess the economic value of the new technology "day surgery mastectomy" for patients, doctors, and medical insurance-related units by building a health economics model. The research will analyze the performance of this technology in overseas markets by reviewing existing literature, and combine relevant data from domestic medical institutions to provide a scientific basis for its future promotion and rule-making in the Chinese market.

Since 2022, the college has signed nearly 15 horizontal research projects, actively implementing scientific research innovation and social service around national strategic needs and the needs of economic and social development.

Founded in 1984, Danaher Corporation is a global innovator in science and technology, dedicated to helping customers around the world address complex challenges and improve their quality of life. Danaher boasts numerous world-renowned brands in demanding and attractive sectors such as health, environment, and industrial applications. With over 20 operating companies and more than 70,000 employees worldwide, Danaher is one of the world's most successful industrial M&A and consolidation companies, and a leader in "empowering" M&A.